Background. The aim of this study was to compare two methods used to measure serum cystatin C (Cys) and their accuracy to predict glomerular filtration rate (GFR). Methods. Three hundred and sixty-seven adult chronic kidney disease (CKD) patients with different functional impairments participated in this study. GFR was determined as the renal clearance of 99m Tc-DTPA. Serum concentrations of cystatin C (SCys) were determined with an immunonephelometric method and with an immunoturbidimetric method. Results. A very high linear correlation was found between the two measurements of SCys (r = 0.929). The mean difference of SCysTurb-SCysNeph was 0.02 ± 0.43 mg/L (not significant). A high logarithmic correlation was also found between SCys and GFR (r was 0.919 for SCysNeph and 0.937 for SCysTurb). By means of multiple regression analysis, we developed formulae to predict GFR from SCysNeph, SCysTurb and SCr. For comparison, GFR was predicted using published formulae. A good agreement was found between predicted GFR and measured GFR. The results showed that the accuracy of SCysNeph, SCysTurb and SCr and of the different prediction formulae were quite similar. Conclusions. The immunoturbidimetric method seems adequate to measure SCys and to predict GFR and its impairment in CKD, at least similar to the immunonephelometric method. The accuracy of SCys and of derived formulae was not higher than that of SCr and SCr-based formulae.
Introduction
The direct measurement of glomerular filtration rate (GFR) is the gold standard for the assessment of renal function in humans. GFR can be measured as the clearance of inulin or other markers, like 99m Tc-DTPA [1, 2] . However, in clinical practice, 24-h creatinine clearance (24-h CCr) or serum creatinine (SCr) is frequently used to evaluate GFR. To overcome the low precision and accuracy of 24 h-CCr [3] [4] [5] , the low sensitivity of SCr and the influence of muscle mass on its relationship with GFR [6] , it has been proposed to predict GFR by equations based on SCr and anthropometric data [7] [8] [9] [10] [11] [12] . However, the standardization of SCr measurements becomes mandatory to avoid differences in predicted GFR due to interlaboratory variability [12] [13] [14] , and prediction formulae should be validated in patients with different body compositions [15] [16] [17] [18] .
Many low-molecular-weight proteins (LMWP), with a molecular weight ranging from 10-25 KDa, are cleared by the plasma through free glomerular filtration, complete tubular resorption and degradation inside tubular cells [19, 20] . As a consequence, their serum concentrations increase progressively with the reduction of GFR. This renal handling is compatible with that of an 'ideal' marker of GFR. Different studies indicate that serum concentration of the LMWP cystatin C (SCys) could be a useful tool to evaluate impairment of GFR, possibly more sensitively than SCr [21] [22] [23] [24] . Thus, prediction formulae to estimate GFR from SCys have also been proposed. Different laboratory methods are currently available to measure SCys, and their different analytical performance can affect the accuracy of SCys to predict GFR in chronic kidney disease (CKD) patients.
The aim of this study was to compare the accuracy of SCys, measured with an immunonephelometric and immunoturbidimetric method, and SCys-based equations to predict GFR in comparison with SCr and SCr-based prediction formulae. The immunonephelometric method requires a dedicated apparatus, while immunoturbidimetric method can be performed on different standard laboratory analysers.
Inclusion criterion was the request of measurement of GFR. Exclusion criterion was unstable renal function, determined from the laboratory and clinical history of patients. The flow diagram, according to the STARD initiative [26] , of the 388 eligible patients is shown in Figure 1 . No patient was excluded from the study. Eight patients had inadequate collection of blood samples for the determination of index tests (SCys and SCr). Thirteen other patients had inadequate measurement of the reference test (GFR). The remaining 367 CKD patients, affected by different kidney diseases with various levels of renal function (SCr 0.40-10.5 mg/dL), were analysed. No patient needed replacement of renal function by dialysis. The study, approved by the Institutional Ethical Committee, was conducted in accordance with the ethical guidelines of the Helsinki declaration. All patients gave their informed consent.
Bioimpedance analysis measurements
Total body electrical impedance (BIA) was measured by using a single frequency (50 kHz, 0.8 mA) impedance analyser (ST-BIA; Akern) in 357/367 patients at the time of GFR measurement [27] . Values of body cell mass (BCM) were recorded as indicators of muscle mass [16, 28] .
Measurement of GFR (reference test)
GFR was measured as the renal clearance of 99m Tc-DTPA [1, 29] . The results were adjusted to the body surface of 1.73m 2 . On the basis of the values of GFR, patients were classified into the different stages of CKD. We used the modified classification which subdivides the Stage 3 into 3a (GFR 45-60 mL/min/1.73m
2 ) and 3b (GFR 30-45 mL/min/1.73m 2 ) [25] .
Measurement of serum concentrations of creatinine and cystatin C (index tests)
Blood samples were drawn at the time of GFR measurement, before breakfast. SCr was measured with a rate-blanked creatinine/Jaffe method (CREA Roche/Hitachi automated analysis for Hitachi 917; Roche Diagnostics, Mannheim, Germany). This method is traceable to isotope dilution mass spectrometry (IDMS) creatinine measurement. SCys was measured with a particle-enhanced immunonephelometric method (N Latex Cystatin C; Siemens, Marburg, Germany) and with an immunoturbidimetric method (Cystatin C Immunoassay; Gentian, Moss, Norway).
Reference ranges for SCr and SCys nephelometric and turbidimetric were determined in two groups of blood donors: 148 subjects (74 women and 74 men) and 155 other blood donors (80 men and 75 women).
Prediction of GFR
GFR was predicted with the most common prediction equations based on SCr and SCys: Cockcroft and Gault Formula (CG-CCr) [7] , Modification of Diet in Renal Disease simplified formula (MDRD-GFR) for IDMS-traceable SCr [12] and Cys-based formula for adults ( SCysGrubb GFR) [30] . CG-CCr values were adjusted to the body surface of 1.73m 2 .
Derivation of new prediction equations for GFR based on SCr and SCys
New prediction equations for GFR were derived using stepwise multiple regression analysis among GFR ( 99m Tc-DTPA) and anthropometric data, SCr or SCys. Men and women were analysed separately. Logarithmic transformation of data was used. The stepwise method enters the different variables sequentially in the model if the significance of the correlation with GFR is < 0.05. After logarithmic resolution, different formulae have been derived to predict GFR.
Statistical analysis
Statistical analysis was performed mainly using MedCalc, version 11.4.2.0 (Mariakerke, Belgium). A P-value < 0.05 was considered significant. The interassay coefficients of variation (CV) for SCysTurb was calculated by means of repeated (15 times) measurements on pooled sera with normal and high cystatin concentration. The CV was also calculated on duplicate measurement of GFR in 15 patients. The significance of the differences among the mean values in the different groups of patients was assessed using the non-parametric MannWhitney test. Wilcoxon test for paired samples was used to evaluate the statistical significance of the differences between the predictions of GFR and measured GFR. The statistical significance of the differences among the correlation coefficients was tested [31] . The agreement between nephelometric and turbidimetric SCys and between measured and predicted values of GFR was evaluated [32] . The distribution of the differences between nephelometric and turbidimetric SCys and between measured and predicted values of GFR was evaluated with mountain plots [33] . The diagnostic accuracy of SCys and SCr and of the prediction equations, as indicators of GFR impairment, was assessed using receiver-operating characteristic (ROC) analysis. Mean prediction error of the estimates of GFR versus measured GFR was calculated as root mean squared error [34] . Reproducibility of duplicate measurements and concordance between nephelometric and turbidimetric measurements of SCys and between predicted and measured values of GFR were evaluated by means of Lin's concordance correlation coefficients [35] .
Results
Reference intervals for SCr, SCysNeph and SCysTurb, measured in blood donors, are reported in Table 1 . As expected, SCr was significantly higher in men than in women (P < 0.0001). SCysNeph values were slightly, but significantly (P < 0.05) higher in men than in women, while no significant gender difference was found for SCysTurb. The interassay CV for SCysTurb, on two pools with a Cys concentration of 1.14 and 2.45 mg/L, was 2.68 and 1.81%, respectively. The interassay CV for SCysNeph was 13. 9 and 8.8% (our Prediction of GFR from serum cystatin Cprevious data on two pools with a Cys concentration of 1.23 and 2.25 mg/L) and those of SCr was 8.0 and 7.1% (our previous data on two pools with Cr concentration of 0.81and 2.88 mg/dL).
The CV of GFR (reference test), calculated from duplicate measurements in 15 patients, was quite low (5.4%). Only in two patients was the difference between duplicate measurements of GFR >10%, and in neither of these was the difference >30%. The strength of agreement between the duplicate measurements was high: the concordance correlation coefficient was 0.9575, the precision 0.9791 and the accuracy 0.9779.
The flow diagram of the 388 eligible patients is shown in Figure 1 . The main anthropometric and clinical data of the 367 examined patients are reported in Table 2 .
A very high linear correlation was found between SCysNeph and SCysTurb (r = 0.929, Figure 2A ). The agreement between SCysNeph and SCysTurb was also satisfactory. In fact, their mean difference was null, and the range of agreement between the two measurements was between −0.9 and 0.8 mg/L ( Figure 2B ). In the great majority of cases (327/367), the percent error of SCysTurb versus SCysNeph was within ±30% of SCysNeph values, independently from the level of GFR ( Figure 2C) . Finally, the differences between the two measurements were symmetrically distributed around the mean value of −0.07 mg/L ( Figure 2D ). The strength of agreement between SCysNeph and SCysTurb was quite high: concordance correlation coefficient was 0.9278. The strength of agreement was significantly higher in females than in males (0.9514 versus 0.9045, P < 0.001). No significant difference was found according to age or body mass index (BMI).
Multiple regression among the dependent variables SCysNeph, SCysTurb, SCr and the independent variables GFR, BCM, age, body weight and body height demonstrated that, besides the level of GFR, SCr increases with BCM and body height, while it decreases with age ( Table 3) . Turbidimetric SCys depends exclusively on GFR, while nephelometric SCys is slightly influenced by BCM, in men.
A very high logarithmic correlation with GFR was found for SCr, SCysNeph and SCysTurb (Figure 3 ). The unique difference among correlation coefficients was a significantly higher correlation with GFR of SCr versus SCysNeph, in women (P < 0.05). Starting already from CKD Stage 2, mean values of SCr, SCysNeph and SCysTurb were significantly higher than in patients at CKD Stage 1 ( Table 4 ). The mean differences between turbidimetric and nephelometric measurements were quite low in all groups of patients ( Table 4 ). The prediction error of turbidimetric versus nephelometric cystatin C was slightly Mean values ± SD; lower and upper reference ranges are reported. *P < 0.05 and **P < 0.0001 indicate the statistical significance between females and males. higher in men than in women, particularly in the group of patients at CKD Stage 5. SCys, either turbidimetric or nephelometric assays, and SCr became higher than their upper limits when GFR was < 64.3, 68.4 and 62.6 mL/min/1. Table 5 ). Overall accuracy, that is the percentage of true positive plus true negative over total number of patients, was slightly higher for turbidimetric SCys (77.7%) than for nephelometric measurement (65.4%) and SCr (67.3%) ( Table 5 ).
In Table 6 the different formulae to predict GFR, derived separately for men and women, with stepwise multiple regression analysis from the combination of age, anthropometric data and SCys, nephelometric or turbidimetric measurement or SCr, are reported. The highest values of multiple correlation coefficient (MCC) were found combining SCr and SCys together with age and, in men, with body weight ( SCr&Cys GFR). The MCC of SCr&Cys GFR was significantly higher than MCC of SCysNeph GFR and SCysTurb GFR, either in men or women. The statistical significance of the other differences among prediction equations are reported in Table 6 . Using the prediction equations reported in Table 6 and the published equations for Cys [36] and creatinine [8, 12] , different estimates of GFR were calculated. A close linear correlation was found between prediction formulae and measured GFR ( Figure 5 ). No significant differences were found between correlation coefficients of prediction formulae Fig. 3 . Correlation plots between GFR and serum cystatin C nephelometric assay, cystatin C turbidimetric assay and SCr. Correlation coefficients between cystatin C nephelometric and GFR: all patients r = 0.9194, women r = 0.9120, men r = 0.9253; correlation coefficients between cystatin C turbidimetric and GFR: all patients r = 0.9373, women r = 0.9320, men r = 0.9437; correlation coefficients between creatinine and GFR: all patients r = 0.9263, women r = 0.9429, men r = 0.9480. In women, the correlation coefficient between SCr and GFR was significantly higher (P < 0.05) than that between nephelometric cystatin C and GFR. No other significant difference was found among correlation coefficients.
based on nephelometric or turbidimetric measurements of Cys. However, the correlation coefficient of SCr&Cys GFR was significantly higher than the majority of other formulae. The correlation coefficient of SCr GFR and those of MDRD-GFR and of CG-CCr were significantly higher than those of SCys-based predictions. Table 4 . Serum concentration of creatinine and cystatin C in groups of patients clustered according to the stage of CKD on the basis of GFR (mL/ min/1.73m
2 ) a CKD Stage a Mean values ± SD. Significance of the differences versus CKD Stage 1 (Mann-Whitney Test): + = P < 0.01; x = P < 0.001; § = P < 0.0001. A good agreement was found between predicted GFR and measured GFR ( Figure 6 ). The range of agreement was similar using SCysTurb or SCysNeph. The best agreement was found between SCr&Cys GFR and true GFR, as indicated by the insignificant mean difference and by the lowest value of the range of agreement. A moderate agreement with GFR was found for SCysTurbGrubb GFR, MDRD-GFR and CG-CCr, while the agreement between GFR and SCysNephGrubb GFR resulted fair. The slopes and the intercepts of the regression lines in Panels 3, 4, 7 and 8 ( Figure 6 ) were statistically significant, indicating that the relationship with GFR of MDRD-GFR, CG-CCr and, more clearly, those of CysNephGrubb and CysTurbGrubb prediction formulae change according to the level of renal function. As a consequence, a negative bias is observed for values of GFR < 60 mL/min/1.73m 2 and a positive bias for GFR >60 mL/min/1.73m 2 .The differences between predicted and measured values of GFR were symmetrically distributed around the 0 difference for SCysNeph GFR and SCysTurb GFR and for SCr&Cys GFR and SCr GFR, while they appear skewed to the left for CGCCr, for SCysTurbGrubb GFR and particularly for SCysNephGrubb GFR, indicating an overestimation of renal function by these formulae (Figure 7 ).
Mean differences and SD of the differences between predicted and measured GFR, concordance correlation coefficient, Pearson's p ( precision) and bias correction factor Cb (accuracy) are reported in Table 7 . No significant difference was found between formulae based on turbidimetric and nephelometric Cys. The highest value of concordance correlation coefficient with GFR was found using the formula which combines SCr and SCys ( SCr&Cys GFR). The concordance correlation coefficient of SCr GFR was higher than those of SCys-based formulae. The other statistically significant differences are reported in Table 7 . The absolute value of mean prediction error decreased from CKD 1 to CKD 5 ( Figure 8 , upper part), being higher in women than in men. SCr&Cys GFR had the best performance. Very similar results were found for SCysNeph GFR and SCysTurb GFR. The highest prediction errors were related to ScysNephGrubb GFR. The value of the relative mean prediction error, expressed as a percentage of the mean value of GFR for each CKD stage (Figure 8 , lower part), remained quite similar at CKD stages from 1 to 4, while increased in patients at CKD Stage 5. Differences were found according to the gender and to the prediction formula, confirming the results obtained from the analysis of absolute prediction errors. The lower precision of prediction formulae at CKD Stage 5 is also demonstrated by the lower percentage of values within the range ±30% from measured GFR in CKD 5 patients (Figure 9 ). Also, in this case, differences were found according to gender and to the prediction formula.
The accuracy of the different methods tested to screen the impairment of GFR, evaluated with ROC plots, were similar (Table 8 ). In particular, no significant difference in the accuracy was found between nephelometric and turbidimetric SCys and between prediction formulae based on nephelometric and turbidimetric SCys. The accuracy of SCys and of SCr was also similar to that of SCys-and SCr-based prediction formulae. SCr&Cys GFR was the most accurate indicator of any level of GFR impairment. In the women with GFR < 90 mL/min/1.73m 2 , the accuracy of SCr&Cys GFR was significantly higher than that of nephelometric SCys. Calculated from data in Figure 4 . 
Discussion
GFR estimation is essential in the evaluation of CKD patients. Prediction equations from SCr or SCys are commonly used to assess kidney function. However, prediction formulae have serious limitations in malnourished and aged patients or to evaluate living kidney donors, when very accurate estimates of GFR are needed. Therefore, it has been suggested that GFR should be more widely measured also in clinical practice [37] . In the present study, GFR was measured with a 'gold standard' Correlation between predicted and measured GFR. SCysNeph GFR and SCysTurb GFR are the new prediction equations for GFR from serum cystatin nephelometric and turbidimetric method, respectively (this study, Table 6 ). SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] ; SCrGFR and CrCysGFR are the new prediction equations for GFR from SCr and from both SCr and cystatin C (this study, Table 5 ), MDRD-GFR, simplified Modification of Diet in Renal Disease study equation formula [12] ; CG-CCr, creatinine clearance Cockcroft and Gault formula [8] .
The identity lines and the regression lines are represented. No significant difference between the correlation coefficients of SCysNeph GFR and SCysTurb GFR. The statistical significance of the other correlation coefficients was as follows: SCr&Cys GFR P < 0.05 versus MDRD-GFR, P < 0.01 versus CG-CCr, P < 0.001versus SCysNeph GFR, SCysTurb GFR, SCysNephGrubb GFR and SCysTurbGrubb GFR; SCr GFR P < 0.01 versus SCysNeph GFR and SCysTurb GFR, P < 0.001 versus SCysNephGrubb GFR and SCysTurbGrubb GFR; MDRD-GFR P < 0.05 versus SCysNeph GFR and SCysTurb GFR, P < 0.001 versus SCysNephGrubb GFR and SCysTurbGrubb GFR; CG-CCr P < 0.05 versus SCysNeph GFR and SCysTurb GFR, P < 0.001 versus SCysNephGrubb GFR and SCysTurbGrubb GFR; SCysNeph GFR P < 0.05 versus SCysNephGrubb GFR; SCysTurb GFR P < 0.05 versus SCysNephGrubb GFR. Fig. 6 . Agreement between predicted and measured GFR. SCysNeph GFR and SCysTurb GFR are the new prediction equations for GFR from serum cystatin nephelometric and turbidimetric method, respectively (this study, Table 6 ). SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] ; SCrGFR and CrCysGFR are the new prediction equations for GFR from SCr and from both SCr and cystatin C (this study, Table 5 ), MDRD-GFR, simplified Modification of Diet in Renal Disease study equation formula [12] ; CG-CCr, creatinine clearance Cockcroft and Gault formula [8] . The mean differences (solid lines) between measured and predicted values of GFR and the ranges of agreement (dashed lines, ±1.96 SD) which encompasses 95% of population are represented.
method ( 99m Tc-DTPA), which has an excellent reproducibility. This high reproducibility is particularly relevant since the imprecision in measured GFR contributes to an appreciable proportion of the cases in which estimated GFR and measured GFR differ by >30% [38] .
The aim of our study was to compare two methods used to measure SCys and their accuracy to predict GFR in comparison with SCr and creatinine-based formulae. The study was performed in a large number of CKD patients, affected by various kidney disease, with different impairment of renal function, from normality to advanced renal failure, up to CKD Stage 5.
The measurements of SCys demonstrated an excellent agreement between nephelometric and turbidimetric assay in the whole range of explored renal function, without differences due to age, BMI or the diagnosis of diabetes. These results are in agreement with a recent study aimed to compare the measures of SCys, by nephelometric, turbidimetric and enzyme-linked immunosorbent assay (ELISA) methods, on sera from 80 normal subjects and 20 renal or cardiac patients [39] . Accuracy and precision of turbidimetric and nephelometric assay were similar, while the ELISA method had a significant bias. These data also indicate that standardization of the SCys assay is needed for implementation of SCys and derived prediction equations in clinical practice [40] . In our patients, the accuracy of nephelometric and turbidimetric SCys and of SCr, as indicators of the different levels of renal impairment, was similar. Our results confirm also that the major determinant of SCys is the level of GFR. However, multiple regression Fig. 7 . Differences between measured and predicted values of GFR. SCysNeph GFR and SCysTurb GFR are the new prediction equations for GFR from serum cystatin nephelometric and turbidimetric method, respectively (this study, Table 5 ). SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] ; SCrGFR and CrCysGFR are the new prediction equations for GFR from SCr and from both SCr and cystatin C (this study, Table 6 ); MDRD-GFR, simplified Modification of Diet in Renal Disease study equation formula [12] ; CG-CCr, creatinine clearance Cockcroft and Gault formula [8] . 'Mountain' plots represent the frequency distribution of the differences between measured and predicted values of GFR. Mean differences and SD of the differences between predicted and measured GFR, concordance correlation coefficient, Pearson's p (precision), bias correction factor Cb (accuracy), calculated according to Lin [35] , are reported. SCysNeph GFR, SCysTurb GFR, SCr GFR and SCr&Cys GFR (prediction formulae from this study, Table 6 ). MDRD-GFR, simplified equation from the Modification of Diet in Renal Disease study [12] , CG-Ccr, Cockcroft and Gault formula [8] ; SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] . Cr, serum creatinine; Cys, serum cystatin C; Neph, nephelometric; Turb, turbidimetric. The statistical significance of the different concordance correlation coefficients were as follows: SCr&Cys GFR (P < 0.0001 versus SCysNephGrubb GFR, SCysTurbGrubb GFR, SCysNeph GFR, SCysTurb GFR, CG-CCr; P < 0.001 versus MDRD-GFR); SCr GFR (P < 0.0001 versus SCysNephGrubb GFR, SCysTurbGrubb GFR; P < 0.0005 versus CG-CCr; P < 0.005 versus SCysNeph GFR, SCysTurb GFR); SCysNeph GFR and SCysTurb GFR (P < 0.001 versus SCysNephGrubb GFR; P < 0.05 versus SCysTurbGrubb GFR); MDRD-GFR (P < 0.0001 versus SCysNephGrubb GFR; P < 0.0005 versus SCysTurbGrubb GFR, P < 0.05 versus CG-CCr); CG-CCr (P < 0.0001 versus SCysNephGrubb GFR); SCysTurbGrubb GFR (P < 0.01 versus SCysNephGrubb GFR).
analysis indicated that the values of SCys in men, when determined with nephelometric assay, were slightly but statistically correlated with BCM, which is an indicator of muscle mass [16, 28] . As expected, the influence of gender and muscle mass on SCr was much more evident and significant than for SCys. These results agree in part with a study which showed that muscle mass affects SCr but not SCys [41] . In any case, in our study, the correlations with GFR resulted very similar for nephelometric and turbidimetric SCys. Our results, while confirming that SCys is only slightly affected by the amount of muscle mass, do not support the expected superiority of SCys and SCys-based formulae versus SCr and SCr-based equations. In fact, SCys was not better correlated with GFR than SCr. To the contrary, in women, SCr was better correlated with GFR than nephelometric SCys. Also, the sensitivities of SCys and SCr as indicators of a slight impairment in GFR were similar. In fact, different from other literature data [42] , in our patients, SCysNeph, SCysTurb and SCr exceeded the upper limit of their reference ranges at similar levels of Percentage of predicted values of GFR within the range ±30% from measured GFR. SCysNeph GFR and SCysTurb GFR are the new prediction equations for GFR from serum cystatin nephelometric and turbidimetric method, respectively (this study, Table 6 ). SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] ; SCrGFR and CrCysGFR are the new prediction equations for GFR from SCr and from both SCr and cystatin C (this study, Table 6 ); MDRD-GFR, simplified Modification of Diet in Renal Disease study equation formula [12] ; CG-CCr, creatinine clearance Cockcroft and Gault formula [8] . Grey circles, all patients; black circles, men; white circles, women.
GFR. Cystatin C equations derived in our study, either with nephelometric or turbidimetric measurements, had a weaker agreement with measured GFR than creatinine-derived equation, as demonstrated by their wider ranges of agreement with GFR. It is also remarkable that no significantly different accuracy was found among the prediction formulae based on SCys or SCr. Interestingly, the predictions based on both SCr and SCys had the best agreement with the measured values of GFR, indicating a complementarity between the two markers, which could be clinically relevant, as indicated by other studies [43] . Prediction formulae allow a simple evaluation of renal function. However, our results indicate that there is no significant advantage of prediction formulae versus the simple measurement of SCys and SCr, as a screening tool. Formulae demonstrated a better accuracy over serum concentrations only when they were based on multiple markers [43] [44] [45] [46] [47] [48] . It is important to remind that the implementation of prediction equations in clinical practice requires standardization of SCys and SCr assays, and knowledge of the factors that can modify their relationship with GFR. The worse performance, demonstrated by the Grubb equation SCr&Cys GFR are the new prediction equations for GFR (this study, Table 6 ). MDRD-GFR, simplified formula from Modification of Diet in Renal Disease study [12] ; SCysNephGrubb GFR and SCysTurbGrubb GFR, Grubb formula for adults [36] ; CG-CCr, creatinine clearance Cockcroft and Gault formula [8] . AUC, areas under the curve, criterion values and standard errors are reported. All values of AUC were statistical significant ( § = P < 0.0001). b AUC of SCr&Cys GFR was statistically higher than that of serum cystatin nephelometric in women (P < 0.05).
when using nephelometric measurements of SCys, with respect to the results obtained using turbidimetric measurements of SCys, confirms that the harmonization of the different assays is a key point for the generalization of a prediction formula. In fact, the Grubb equation was derived on the basis of turbidimetric measurements of SCys. Actually, the assay for SCys, in contrast to SCr,
has not yet been standardized. In addition, a lower analytical accuracy of SCys has been hypothesized, based on the large intraindividual variation observed for SCys versus SCr [49] . Furthermore, even the clinical presentation of CKD may affect the relationship between SCys and GFR [44] . Finally, different papers suggest that extrarenal disease, peripheral arterial disease and cardiovascular disease can also affect the relationship between SCys and GFR [50] [51] [52] [53] . In CKD patients, SCys can identify patients with the highest risk for cardiovascular disease, heart failure and kidney failure outcomes more efficiently than SCr or GFR [54] , and elevated SCys is also associated with an increased prevalence of metabolic abnormalities [55] . In CKD patients, SCys may also be affected by age, gender, ethnicity, diabetes, serum albumin and C-reactive protein [56] . Note that recent data demonstrated the down-regulation of cystatin C synthesis in response to inflammatory stimuli [57] . Thus, it is possible to hypothesize that in CKD patients, SCys is a more sensitive indicator of cardiovascular risk than SCr and GFR. This peculiar behaviour, which is useful for the assessment of mortality risk, raises the doubt that extrarenal factors may reduce the reliability of SCys and related formulae as 'pure' indicators of GFR impairment. Also in the general population, SCys appeared to be influenced by factors other than renal function, and SCys-based estimates of GFR were not superior to SCr-based estimates [36, 58] .
In conclusion, the immunoturbidimetric method has a very low analytical variability and seems adequate, or at least similar to the immunonephelometric method, to measure SCys and to predict GFR and its impairment in CKD. SCys and SCys-based prediction formulae demonstrated a similar accuracy as indicators of the different stages of CKD. No relevant difference was found between the accuracy of SCr and SCr-based formulae.
